Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity

SCOPUS: re.jinfo:eu-repo/semantics/publishe

Diffuse bilateral pneumopathies in patients with cancer

SCOPUS: re.jinfo:eu-repo/semantics/publishe

Spontaneous hyperuricemic acute renal failure on oncologic emergency

info:eu-repo/semantics/publishe

Fatal lactic acidosis in malignant histiocytosis

info:eu-repo/semantics/publishe

Case 4: A small cell tumor

SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Expérience récente de la chimiothérapie intensive avec greffe de moëlle autologue dans le traitement des tumeurs solides.

SCOPUS: re.jinfo:eu-repo/semantics/publishe

Role of intensive care unit in a medical oncology department

SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Autoimmune lymphoproliferative syndrome (ALPS). Case report and family history.

Autoimmune lymphoproliferative syndrome (ALPS) is a rare disease caused by defective lymphocyte apoptosis and is characterized by non-malignant lymphoproliferation, hepatosplenomegaly, autoimmune manifestations and increased risk of both Hodgkin's and non-Hodgkin's lymphoma. Most forms of the disease are due to germ line mutations of the FAS gene and manifest during the first years of life with fluctuating lymphadenopathies, hemolysis, immune thrombocytopenia. During the second decade of life disease manifestations improve spontaneously but autoimmune problems still occur and there is an increased risk of lymphoproliferative malignancy. We describe a typical case of ALPS in a now 44 year old man, followed since the age of 2 for disease manifestations that were unclear at the beginning.Case ReportsJournal ArticleSCOPUS: ar.jinfo:eu-repo/semantics/publishe

Intensive multiple drug induction chemotherapy for small-cell lung cancer: A pilot study

SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Phase I trial with carbetimer given on a 5 day schedule

info:eu-repo/semantics/publishe